Drug Profile
Vermiculin
Alternative Names: VermiculineLatest Information Update: 30 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Autoimmune disorders
Most Recent Events
- 03 Jun 1997 New profile
- 03 Jun 1997 Preclinical development for Autoimmune disorders in Slovakia (Unknown route)